Postnatal corticosteroid therapy in bronchopulmonary dysplasia - why animal studies disagree with clinical trials?
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
24 Jun 2024
24 Jun 2024
Historique:
received:
14
04
2024
accepted:
07
06
2024
revised:
03
06
2024
medline:
25
6
2024
pubmed:
25
6
2024
entrez:
24
6
2024
Statut:
aheadofprint
Résumé
The systematic review and meta-analysis of newborn animal models by Irene Lok et al. is the first to extensively summarize the literature regarding postnatal systemic corticosteroid use on lung development of newborn rodent models. The meta-analysis showed that the use of postnatal corticosteroids resulted in a reduction in body weight along with persistent alveolar simplification. The most frequently used corticosteroid was dexamethasone. Corticosteroids have been extensively used in clinical trials in preterm newborns. Trials using early systemic administration of corticosteroids reduced the rate of BPD or mortality with no increase in the rates of cerebral palsy. Use of late systemic corticosteroids (administered >7 days after birth) also reduced the rate of BPD, mortality, and combined outcome of mortality or BPD. Late systemic corticosteroids showed no impact on the rates of neurodevelopmental outcomes in later childhood. It is important to note that later stages of inflammation leading to a more severe form of BPD continues to be a problem with no clear therapy in sight. The authors made a critical point in their paper - the negative effects of steroids were greater in the normal lung control animals than in the injured. This conveys caution in using steroids in a prophylactic manner. IMPACT: Use of systemic corticosteroids in clinical trials have shown good response in preterm neonates evidenced by reduced rate of bronchopulmonary dysplasia. Rodent models have not shown a similar beneficial response. Use of systemic corticosteroids have caused greater arrest of lung development in rodent models with normal lungs compared to those with lung damage.
Identifiants
pubmed: 38914764
doi: 10.1038/s41390-024-03361-7
pii: 10.1038/s41390-024-03361-7
doi:
Types de publication
Journal Article
Comment
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentOn
Informations de copyright
© 2024. The Author(s).
Références
Cummings, J. & Pramanik, A. K. Committee On Fetus And Newborn Postnatal corticosteroids to prevent or treat chronic lung disease following preterm birth. Pediatrics 149, e2022057530 (2022).
doi: 10.1542/peds.2022-057530
pubmed: 37917016
Yoder, B. A., Harrison, M. & Clark, R. H. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants. Pediatrics 124, 673–679 (2009).
doi: 10.1542/peds.2008-2793
pubmed: 19620192
Doyle, L. W. Victorian Infant Collaborative Study Group et al. Ventilation in extremely preterm infants and respiratory function at 8 years. N. Engl. J. Med. 377, 329–337 (2017).
doi: 10.1056/NEJMoa1700827
pubmed: 28745986
Balany, J. & Bhandari, V. Understanding the impact of infection, inflammation, and their persistence in the pathogenesis of bronchopulmonary dysplasia. Front. Med. 2, 90 (2015).
doi: 10.3389/fmed.2015.00090
Baden, M. et al. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics 50, 526–534 (1972).
doi: 10.1542/peds.50.4.526
pubmed: 4561296
Avery, G. B., Fletcher, A. B., Kaplan, M. & Brudno, D. S. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75, 106–111 (1985).
doi: 10.1542/peds.75.1.106
pubmed: 3880879
Doyle, L. W. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Neonatology 118, 244–251 (2021).
doi: 10.1159/000515950
pubmed: 33975319
Lok I. M. et al. Effects of postnatal corticosteroids on lung development in newborn animals. A systematic review. Pediatr. Res. https://doi.org/10.1038/s41390-024-03114-6 .
Berger, J. & Bhandari, V. Animal models of bronchopulmonary dysplasia. The term mouse models. Am. J. Physiol. Lung Cell Mol. Physiol. 307, L936–L947 (2014).
doi: 10.1152/ajplung.00159.2014
pubmed: 25305249
pmcid: 4269689
Hoshikawa, Y. et al. Hypoxia induces different genes in the lungs of rats compared with mice. Physiol. Genom. 12, 209–219 (2003).
doi: 10.1152/physiolgenomics.00081.2001
Irvin, C. G. & Bates, J. H. Measuring the lung function in the mouse: the challenge of size. Respir. Res. 4, 4 (2003).
doi: 10.1186/rr199
pubmed: 12783622
pmcid: 184039
Doyle, L. W., Cheong, J. L., Hay, S., Manley, B. J. & Halliday, H. L. Late (>/= 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst. Rev. 11, CD001145 (2021).
pubmed: 34758507
Baud, O., Alberti, C., Mohamed, D. & Watterberg, K. Low-dose hydrocortisone in extremely preterm infants - Authors’ reply. Lancet 388, 1158–1159 (2016).
doi: 10.1016/S0140-6736(16)31611-7
pubmed: 27650090
Baud, O. et al. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet 387, 1827–1836 (2016).
doi: 10.1016/S0140-6736(16)00202-6
pubmed: 26916176
Baud, O. et al. Association between early low-dose hydrocortisone therapy in extremely preterm neonates and neurodevelopmental outcomes at 2 years of age. JAMA 317, 1329–1337 (2017).
doi: 10.1001/jama.2017.2692
pubmed: 28384828
Onland, W. et al. Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or bronchopulmonary dysplasia among very preterm infants receiving mechanical ventilation: a randomized clinical trial. JAMA 321, 354–363 (2019).
doi: 10.1001/jama.2018.21443
pubmed: 30694322
pmcid: 6439762
Watterberg, K. L. et al. Hydrocortisone to improve survival without bronchopulmonary dysplasia. N. Engl. J. Med. 386, 1121–1131 (2022).
doi: 10.1056/NEJMoa2114897
pubmed: 35320643
pmcid: 9107291
Richa Lakhotia S. A. B., Zackula R., Raghuveer T. S. Systemic steroids to prevent bronchopulmonary dysplasia in preterm infants: a systematic review, including long-term follow-up, and meta-regression https://2023.pas-meeting.org/fsPopup.asp?Mode=presInfo&PresentationID=1213196 (2023).